Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 415,000
+26,500 (6.82%)
Oct 30, 2026, 3:30 PM KST
Hanmi Pharm. Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Hanmi Pharm. stock has a consensus rating of "Buy" and an average price target of ₩635,455. The average 1-year stock price forecast is 53.12% higher than the current stock price, while the lowest is ₩560,000 (+34.94%) and the highest is ₩730,000 (+75.90%).
Price Target: ₩635,455 (+53.12%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Hanmi Pharm. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 6 | 6 | 5 | 5 |
| Buy | 8 | 7 | 6 | 5 | 6 | 6 |
| Hold | 1 | 1 | 0 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 13 | 12 | 12 | 11 | 11 |
Financial Forecast
Revenue This Year
1.85T
from 1.55T
Increased by 19.27%
Revenue Next Year
1.75T
from 1.85T
Decreased by -5.45%
EPS This Year
25.06K
from 13.36K
Increased by 87.56%
EPS Next Year
15.90K
from 25.06K
Decreased by -36.57%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.